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ABSTRACT 
Objective: Chronic Renal Failure is a worldwide public health problem with an increasing incidence and prevalence, poor outcomes and high cost of 
treatment due to co-morbidities and Polypharmacy. The aim of this study was to describe drug utilization pattern of patients with chronic renal 
failure in a tertiary care hospital. 
Methods: The study was conducted between July -2013 to December-2013. In total 150 patients were identified and 135 patients were recruited 
for further study. Study subject medical record and prescription was reviewed on their regular hospital visit. Those were missed the followup, their 
medical records and prescription were reviewed from the medical record department 
Results: In this study, male subjects (62.85 %) predominated; 37.05% of the patients were in the age group of 51 to 60 years. The mean age of 
subjects was 53.26 ±15.69 years. The average number of drugs prescribed per prescription was 5.26 ± 3.79. 
Conclusion: The prevalence of Polypharmacy was high in patients with CRF. Diuretics, anti hypertensive and anti diabetic drugs were used more 
frequently in chronic renal failure patients. Moreover time to time studies are required to improve management strategy and quality of life of 
patients. 
Keywords: Prescribing pattern, Chronic Renal Failure, Polypharmacy. 
 
INTRODUCTION 
Chronic Renal Failure (CRF) is a worldwide public health problem 
with an increasing incidence and prevalence, poor outcomes and 
high cost of treatment due to co-morbidities and Polypharmacy[1,2]. 
The increasing importance, of drug utilization studies as a valuable 
investigation resource in pharmacoepidemiology. It has been 
bridging it with other health related areas, such as 
pharmacovigilance and pharmacoeconomics [3]. Drug utilization 
studies may use to evaluate the drug use at a population level, 
according to demographic, morbidity and other characteristics. 
These studies are useful to monitor the pattern of drugs from 
particular therapeutic categories where the problems can be 
anticipated [4, 5, 6]. 
MATERIALS AND METHODS 
As compared with pre marketing clinical trials, 
post marketing studies are helpful to improve the therapeutic 
strategy and to monitor the incidence of adverse drug reactions and 
Drug interactions [7]. The cost of treatment in CRF was increased 
due to co-morbidities and use of number of drugs for same 
condition. Inappropriate use of drugs may increase the change of 
adverse drug reactions and reduce the quality of life of patients. To 
describe these issues, the study was planned to assess drug 
utilization pattern of patients with Chronic Renal Failure in a 
tertiary care hospital.  
The study was carried out in the department of nephrology, PSG 
Hospital. The study was approved by Institutional Human Ethics 
Committee. After obtained informed consent, the adult male and 
female patients were recruited to the study. Children, pregnant, 
breast feeding women and patient on haemodialysis were excluded 
from the study. During the study period, patients were interviewed 
and their medical records were reviewed to assess the drug 
utilization pattern. 
Study population 
The study was conducted between July -2013 to December-2013. In 
total 150 patients were identified and 135 patients were recruited 
for further study. Study subject medical record and prescription 
were reviewed on their regular hospital visit to the nephrology 
department of PSG Hospitals, Coimbatore. Those were missed the 
follow-up, their medical records and prescription were reviewed 
from the medical record department. 
Statistical analysis 
Documented Data was analyzed by using Graphpad prism version 
4.0. Results were expressed as Mean ± Standard Deviation (SD). Non 
parametric values were expressed as the percentage. 
RESULTS 
In total, 150 Chronic Renal Failure patients were identified during 
the study period of six months. Of this, 135 patients were included 
for the study as per the inclusion and exclusion criteria (n=135). The 
patient’s medical record and prescription were reviewed to describe 
the drug utilization pattern.  
Demographics 
Out of 135 patients studied, 72 were male and 63 were female (Table-
1). As per the study result, the percentage of male patients (62.85%) 
was greater than the percentage of female patients (37.14 %). 
 
Table 1: Gender distribution 
Sex No. of Patient Percentage (%) 
Male 72 53.33 
Female 63 46.66 
 
More number, of patients with in the age group of 51 to 60 years 
(16, 45.71 %). (Table -2) the mean age was 53.26 ±15.69. The male 
and female subjects with the age group of 51-60 years were the 
highest in number by 26 (36.11 %) and 24 (38.09 %) respectively.  
Co-morbidity assessment 
The most frequently encountered co-morbidities were related to 
cardio vascular system. The more number of patients had 
hypertension, diabetes and anaemia as co-morbidities.  
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In total 135 subjects 112 (82.96 %) with hypertension and 98 patients 
with (72.59 %) diabetes were reported during the study period. 
(Table-3). 
 
Table 2: Age distribution 
Age  Male Female Total Percentage (%) 
20-40 Yrs  8 4 12 8.89 
41-50 yrs  14 13 27 20.01 
51-60 Yrs  26 24 50 37.03 
61-70 Yrs  17 20 37 27.41 
>70 Yrs  7 2 09 6.67 
Mean Age 53.26 ±15.69* 
*Mean ± Standard Deviation, Yrs – Years 
 
Polypharmacy  
A total of 135 prescriptions were reviewed, 116 prescriptions had 
more than five drugs (85.92 %). The prevalence of Polypharmacy 
was high in CRF patients. The average number of drugs prescribed 
per prescription was 5.26 ± 3.79. (Table-4) 
Drug utilization pattern 
The study results showed that cardiovascular drugs, particularly 
anti hypertensive agents were prescribed more than other drugs. 
Clacium channel blockers were used frequently with the 
combination of Beta blockers and angitensin-II receptor blocker. 
Anti -coagulant of Aspirin with Clopidogrel was prescribed for 28 
patients (20.74 %). In dyslipidaemia, atorvasatin was prescribed for 
56 patients (41.48 %). (Table-5). 
DISCUSSION 
The CRF population is on the rise worldwide due to increased 
incidence of diabetes and cardiovascular diseases. In other hand, 
inappropriate use of drugs and poly pharmacy make these 
populations vulnerable to drug induced kidney diseases [14]. 
In this study, male subjects (62.85 %) predominated; 37.05% of the 
patients were in the age group of 51 to 60 years. The mean age of 
subjects was 53.26 ±15.69 years. The majority of these subjects had 
family history of cardio vascular diseases. The morbidity pattern in 
these subjects was quite similar to what is commonly found CRF 
patients in India. The common morbidities included cardiovascular 
conditions like Systemic Hypertension, Diabetes mellitus and 
disorders of the neurological Diseases. In an earlier study the 
remarkable feature of psychiatric conditions were noted from 
western countries in the geriatric patients [8].  
In 
India, limited data are available on drug utilization in CRF 
population.  
The negligible prevalence of mental health problem in our study 
could be due to improved awareness regarding CRF among patients 
and family members. The Average number of drugs prescribed per 
prescription is an essential index to measure the degree of 
polypharmacy [9]. Also, it provides scope for systemic review and 
educational intervention in prescribing practices [13]. In this study 
the mean number of drugs per prescription was 5.26 ± 3.79, which 
could be due to prevalence of co-morbidities. It demonstrated that 
the polypharmacy or over prescribing of drugs in CRF patients may 
lead to risk of adverse drug reaction and drug interaction. Other 
hospital-based studies have reported higher value [10].
Anaemia and dyslipidemia were fairly prevalent in the study 
population of CRF patients other than hypertension and diabetes 
mellitus. Patients with diabetes were mostly having associated 
dyslipidemia. They were treated with Glimipride (45.93%) or in 
combination with metformin. Most of the CRF patients with 
hypertension were treated with metoprolol and amlodipine or both. 
In this study, the average number of drugs used in CRF patients for 
mo-morbidities were same like other studies reported [11, 12]. 
Ferrus fumarate (41.48%) and folic acid (44.48%) were used 
frequently to treat anaemia. In this study of polypharmacy 
prevalence rate was high, it could be due to inclusion of proton 




Table 3: Co-morbidity assessment 
Co-morbidity  Male Female Total Percentage (%) 
Hypertension  70 42 112 82.96 
Diabetes  64 34 98 72.59 
Anaemia 58 62 120 88.89 
Dyslipidaemia 30 26 56 41.48 
Ocular disease 11 13 25 18.51 
Neurological Disease 18 21 39 28.89 
ENT Disease 05 11 16 11.85 
 
Table 4: Polypharmacy Assessment 
No. of Drugs Prescribed Male Female Total Percentage (%) 
Less than 5 Drugs 11 8 19 14.07 
More than 5 Drugs 61 55 116 85.92 
Avg. No of Drugs/ Prescription 5.26 ± 3.79* 
*Mean ± Standard 
 
Table 5: Drug utilization pattern in CRF patients 
Name of the Drugs No. of patient Percentage (%) 
Beta Blocker   
Metaprolol 28 20.74 
Atenolol  24 17.78 
Calcium Channel Blocker   
Amlodipine  15 11.11 
Felodipine  7 5.19 
Angiotensin - II Receptor Antagonists   
Losarton  32 23.70 
Telmisartan  42 31.11 
Anti-coagulant drug    
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Aspirin + Clopidogrel  28 20.74 
α1- Receptor Antagonist    
Prazosin  8 5.93 
Alfuzosin  5 3.70 
HMG-CoA Reductase Inhibitor   
Atorvastatin  56 41.48 
Anti Diabetics   
Metformin  36 26.67 
Glyclazide 12 8.89 
Glimipride  62 45.93 
Steroids   
Prednisolone  16 11.85 
Anaemic Drug   
Folic acid 60 44.44 
Ferrus fumerate  56 41.48 
Vitamin and Mineral 4 2.96 
Calcium carbonate and vitamin D3 22 16.30 
Vitamin B. Complex  67 49.63 
Mecobalamin +Alpha Lipoic Acid 56 41.48 
Diuretics   
Spironolactone+Hydroflumethazide  72 53.33 
Furosemide 26 19.26 
Torsemide 37 27.41 
Proton Pump Inhibitor   
Pantaprazole 112 82.96 
Others   
Sodium Bicarbonate 126 93.33 
Furosemide (19.26%) and spironolactone+Hydroflumethazide (53.33 %) were prescribed for diuretic therapy in CRF patients. Co-morbity of 
anaemia was treated with folic acid (44.44%) and ferrus fumarate (41.48 %). Proton Pump Inhibitor (PPI) and Vitamin B-complex containing 
preparations were prescribed with the high prevalence of 82.96% and 49.63% respectively.  
 
CONCLUSION 
In the present study, the prevalence of Polypharmacy was high in 
patients with CRF. Diuretics, anti hypertensive and anti diabetic 
drugs were used more frequently in chronic renal failure patient 
because of the high prevalence of co-morbidities. The value of 
indiscriminate use of anticoagulants and vitamins is valuable 
addition to the effective medications for secondary prevention of 
high risk patients. Moreover time to time studies is required in drug 
utilization pattern to improve management strategy and quality of 
life of patients. However, targeted education of the prescribers and 
dissemination of treatment guideline could facilitate rational use of 
drugs and adherence to treatment guidelines. 
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